Fundraising Fox
Engrail Therapeutics
San Diego, US · Founded 2019 · 32 employees on LinkedIn · 11 known investors
Find your way into Engrail Therapeutics
Sign up to see every warm intro you have to Engrail Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Engrail Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders. Founded in 2019, it focuses on the neuroscience area to treat central nervous system conditions.
Founders & leadership
Engrail Therapeutics was founded in 2019 by Stephen.
Investors · 11
How we know: Foresite Capital's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Longwood Fund's portfolio page · the company's own site · longwoodfund.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Pivotal Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RiverVest Venture Partners's portfolio page · the company's own site · a partner's Signal profile · funding news · Not right? Tell us
How we know: Ysios Capital's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · eightroads.com · Not right? Tell us
How we know: the company's own site · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements$314M disclosed across 2 rounds · 2024
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Engrail Therapeutics do?
- Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders. Founded in 2019, it focuses on the neuroscience area to treat central nervous system conditions.
- Who founded Engrail Therapeutics?
- Engrail Therapeutics was founded by Stephen in 2019.
- Who are Engrail Therapeutics's investors?
- Engrail Therapeutics's investors include Foresite Capital, Longwood Fund, Norwest Venture Partners, Pivotal Life Sciences, RiverVest Venture Partners, Ysios Capital, abrdn plc, Eight Roads Ventures and 3 more.
- How much funding has Engrail Therapeutics raised?
- Engrail Therapeutics has disclosed $314M raised across 2 rounds.
- Where is Engrail Therapeutics headquartered?
- Engrail Therapeutics is headquartered in San Diego, US.